BALTIMORE--The Johns Hopkins University School of Medicine here has signed a five-year research agreement with Genzyme Molecular Oncology aimed at identifying cancer-related genes. Hopkins researcher Kenneth Kinzler will use Serial Analysis of Gene Expression (SAGE) technology to identify and analyze gene expression in cancer. Kinzler is the coinventor of SAGE.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.